XENT

Intersect ENT, Inc

Delisted

XENT was delisted on the 12th of May, 2022.

120 hedge funds and large institutions have $776M invested in Intersect ENT, Inc in 2019 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 42 increasing their positions, 40 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
120
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$22.3M
Puts
$2.95M
Net Calls
Net Calls Change

Top Buyers

1 +$9.1M
2 +$6.71M
3 +$6.22M
4
Jennison Associates
Jennison Associates
New York
+$5.8M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$5.53M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$1.37M
52
$1.2M
53
$1.17M
54
$1.15M
55
$1.12M
56
$1.07M
57
$1.03M
58
$902K
59
$898K
60
$820K
61
$770K
62
$756K
63
$747K
64
$737K
65
$687K
66
$660K
67
$658K
68
$647K
69
$644K
70
$612K
71
$579K
72
$569K
73
$505K
74
$498K
75
$479K